Max Healthcare Institute Ltd Q2 FY27 results (latest), Jul–Sep 2026 →Revenue ₹2,569 Cr +20.3% YoYSee revenue, profit and what management said. You are viewing Q1 FY26.
MH

Max Healthcare Institute Ltd

Q1 FY26Healthcare Services

Max Healthcare Institute Q1 FY26 earnings call: Revenue & Margins

Q1 FY26 earnings call: what management said on revenue, margins and capex.

Revenue
₹2,028Cr
+31.4% YoY
+6.2% QoQ
Net profit
₹308Cr
+30.5% YoY
−3.4% QoQ
Margin
26%
+1 pp YoY
−1 pp QoQ
Price₹1,000
Market cap₹98.2K Cr
P/E65.6

The short version

Max Healthcare reported a strong 27% year-on-year revenue growth in Q1 FY '26, driven by successful hospital acquisitions and integrations. Max Healthcare reported 27% YoY growth in revenue and 23% growth in operating EBITDA in Q1 FY26, marking 19 consecutive quarters of YoY growth, indicating strong ongoing momentum.

From Max Healthcare Institute Ltd's Q1 FY26 earnings-call transcript · updated 23 Aug 2026.

Revenue & Sales Performance

  • Max Healthcare reported a strong 27% year-on-year revenue growth in Q1 FY '26, driven by successful hospital acquisitions and integrations.
  • Existing units showed a 16% revenue growth, with like-for-like ARPOB growth of 5% year-on-year.
  • Occupancy in base hospitals is around 80%, indicating capacity constraints; growth is expected from new bed additions.
  • Approximately 1,000 brownfield and 500 greenfield beds are expected to be commissioned in FY '26, driving volume growth.
  • New hospitals like Lucknow and Nagpur are contributing significantly, with Lucknow showing 97% revenue growth year-on-year.
  • Noida and Dwarka facilities are expected to see acceleration in performance post-integration.
  • International patient revenue grew by 32% year-on-year, bolstered by expanded marketing and new geographies.

2 more points from Max Healthcare Institute Ltd's call on revenue

Create a free account to keep reading this call

Profitability & Margins

See what Max Healthcare Institute Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

  • Max Healthcare is actively expanding with ongoing and planned projects including:
  • 268 beds at Nanavati Phase 1, commissioning basements to third floors, starting soon.
  • 400 beds at Max Smart, Saket Complex, with phased commissioning expected by end Q2 FY '26.
  • Expansion at Max Lucknow to increase capacity from 413 to 520 beds by FY end.
  • 500 beds under construction at Sector 56 Gurgaon, expected commissioning by FY end.
  • 100 beds at Max Nagpur, awaiting environmental clearance; project to complete within 24 months.
  • 397 beds at Patparganj, environmental clearance received, construction underway.
  • 550 beds at Max Vikrant, Saket Complex, pending Forest Department clearance.
  • 400 beds at Zirakpur, Mohali under fast construction, expected completion in 24 months.
  • 140 beds expansion at Max Vaishali, demolition underway, completion in 30 months.
  • New 130-bed built-to-suit hospital in Dehradun, Board-approved lease agreement.
  • Rs. 435 crores deployed towards capacity expansions and upgrades in Q1 FY '26.

2 more points from Max Healthcare Institute Ltd's call on capex

Create a free account to keep reading this call

Top-ranked in Healthcare Services

Ranked on what management guided this quarter

Guidance-ranked
Rev 1Mar 1
Rev 1Mar 3
3
Rev 2Mar 1
4
Rev 2Mar 1
5
Rev 2Mar 1
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Max Healthcare Institute Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

  • Max Healthcare has several ongoing expansion projects contributing to its order book:
  • 400 beds at Zirakpur, Mohali: Approvals received; site work progressing; expected completion within 24 months.
  • 140 beds at Max Vaishali: Demolition underway; building plans being filed; expected completion within 30 months.
  • 500 beds at Thane: Master plan finalizing; detailed drawings being prepared; submissions starting by end of the quarter.
  • 250 beds at Pitampura, Delhi: Drawings submitted; site cleanup completed; construction to start upon approvals.
  • 268 beds at Nanavati Phase 1: Advanced commissioning stages.
  • 400 beds at Max Smart, Saket: Progressing; phased commissioning expected by end of Q2 FY '26.
  • Max Lucknow expansion: Increasing capacity from 413 to 520 beds by FY end.
  • 500 beds at Sector 56 Gurgaon: Structural work in progress; commissioning expected by FY end.
  • 100 beds at Max Nagpur: Environmental clearance awaited; project expected completion in 24 months.
  • 397 beds at Patparganj: Environmental clearance received; work in progress.

2 more points from Max Healthcare Institute Ltd's call on order book

Create a free account to keep reading this call

Max Healthcare Institute Ltd — Quarterly revenue & net profit

Revenue Net profit
Jun 2025Q1 FY26
Sep 2025Q2 FY26
Dec 2025Q3 FY26
Mar 2026Q4 FY26
Jun 2026Q1 FY27
Sep 2026Q2 FY27

Max Healthcare Institute Ltd Q1 FY26 results — key figures

Max Healthcare Institute Ltd Q1 FY26 reported results vs Q1 FY25, ₹ crore
₹ CrQ1 FY26Q1 FY25YoYQ4 FY25QoQ
Revenue2,0281,543+31.4%1,910+6.2%
Operating profit (EBITDA)523387+35.1%512+2.1%
Operating margin26%25%+1 pp27%-1 pp
Profit before tax400321+24.6%402-0.5%
Net profit (PAT)308236+30.5%319-3.4%
EPS (₹)3.172.43+30.5%3.28-3.4%

Source: reported quarterly figures (Screener), ₹ crore.

Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹2.6K Cr, net profit ₹414 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Others in Healthcare Services this season

  • Aster DM Quality (Q1 FY26)

    Recent quarters saw subdued volume growth due to leadership changes and seasonal effects, but an 8% volume growth was achieved in Q1 FY26, improving from 2% in…

  • Dr Agarwal's Hea (Q1 FY26)

    70 crores via preferential allotment to AEHL for CAPEX plans, particularly the flagship facility at Cathedral Road, indicating capacity and service…

  • Syngene International (Q1 FY26)

    Operating EBITDA grew 21% YoY in Q1 FY '26 with margins rising to ~24% from 22% last year. Key concall takeaways from Syngene International Ltd's Q1 FY26…

  • Yatharth Hospital & Trauma Care Services (Q1 FY26)

    International patient business is growing but will remain around 10% of revenue, positively impacting ARPOB without hurting margins. Key concall takeaways from…

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Max Healthcare Institute Ltd and 15K+ more earnings calls,
for less than your morning chai

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Max Healthcare Institute Ltd Q1 FY26 results?

Max Healthcare reported a strong 27% year-on-year revenue growth in Q1 FY '26, driven by successful hospital acquisitions and integrations. Max Healthcare reported 27% YoY growth in revenue and 23% growth in operating EBITDA in Q1 FY26, marking 19 consecutive quarters of YoY growth, indicating strong ongoing momentum.

What is Max Healthcare Institute Ltd share price analysis?

Max Healthcare Institute Ltd currently shows a neutral. The stock trades at a P/E of 65.6 with a market cap of ₹98,161 Cr. Investors should review the full earnings analysis for detailed insights.

Keep Max Healthcare Institute Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.